UNH
UnitedHealth Group Incorporated NYSE Listed Oct 17, 1984$400.96
+0.36%
vs $399.53
Mkt Cap $364.9B
52w Low $237.77
93.1% of range
52w High $413.00
50d MA $372.67
200d MA $333.56
P/E (TTM)
30.3x
EV/EBITDA
17.7x
P/B
3.6x
Debt/Equity
0.8x
ROE
36.5%
P/FCF
22.7x
RSI (14)
65.80
ATR (14)
$8.85
Beta
0.41
50d MA
$372.67
200d MA
$333.56
Avg Volume
7.1M
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services. The OptumHealth segment provides access to networks of care provider specialists, health management services, care delivery, consumer engagement, and financial services. This segment serves individuals directly through care delivery systems, employers, payers, and government entities. The OptumInsight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The OptumRx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and compounding pharmacy, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was incorporated in 1977 and is based in Minnetonka, Minnesota.
1 Health Drive · Eden Prairie, MN 55344 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 21, 2026 | AMC | 6.58 | 7.23 | +9.9% | 346.01 | +1.4% | +2.2% | +0.3% | +0.1% | -0.1% | +3.4% | — |
| Jan 27, 2026 | AMC | 2.10 | 2.11 | +0.5% | 282.70 | +0.4% | +4.0% | -0.6% | -1.8% | -0.5% | -0.5% | — |
| Oct 28, 2025 | AMC | 2.80 | 2.92 | +4.3% | 367.84 | -1.0% | -3.4% | -3.0% | -0.9% | -2.3% | -0.9% | — |
| Jul 29, 2025 | AMC | 4.45 | 4.08 | -8.3% | 261.07 | +1.4% | +1.9% | -6.2% | -4.7% | +1.4% | +4.2% | — |
| Apr 17, 2025 | AMC | 7.29 | 7.20 | -1.2% | 454.11 | -1.0% | -6.3% | +0.4% | +0.2% | -0.9% | -1.3% | — |
| Jan 16, 2025 | AMC | 6.74 | 6.81 | +1.0% | 510.59 | -1.0% | -0.2% | +3.0% | -1.0% | +1.9% | +0.5% | — |
| Oct 15, 2024 | AMC | 7.00 | 7.15 | +2.1% | 556.29 | +0.1% | +2.7% | -0.9% | +0.6% | +0.3% | -0.3% | — |
| Jul 16, 2024 | AMC | 6.65 | 6.80 | +2.3% | 548.87 | +0.9% | +4.4% | -1.6% | +0.2% | -1.2% | -0.7% | — |
| Apr 16, 2024 | AMC | 6.61 | 6.91 | +4.5% | 468.89 | +2.1% | +2.2% | +3.0% | +1.6% | -2.0% | -1.0% | — |
| Jan 12, 2024 | AMC | 5.98 | 6.16 | +3.0% | 521.51 | +0.4% | -0.5% | +1.1% | -1.6% | -2.5% | +1.9% | — |
| Oct 13, 2023 | AMC | 6.32 | 6.56 | +3.8% | 539.40 | +0.7% | -0.3% | -0.3% | -0.1% | -0.8% | -0.9% | — |
| Jul 14, 2023 | AMC | 5.99 | 6.14 | +2.5% | 480.17 | +0.2% | +0.8% | +3.3% | +0.7% | +0.1% | +0.5% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17 | Leerink Partners | Reiterates | Outperform | $462 | $407.65 | $409.12 | +0.4% | -2.0% | +0.4% | — | — | — |
| Jun 4 | BofA Securities | Upgrade | Neutral → Buy | $450 | $377.00 | $390.00 | +3.4% | +5.2% | +0.8% | +1.8% | +1.6% | -1.3% |
| Apr 28 | JP Morgan | Maintains | Overweight → Overweight | — | $354.69 | $356.84 | +0.6% | +3.4% | +1.1% | -0.1% | -0.5% | +0.5% |
| Apr 23 | TD Cowen | Maintains | Hold → Hold | — | $353.52 | $354.68 | +0.3% | +0.3% | +0.1% | -0.1% | +3.4% | +1.1% |
| Apr 22 | Truist | Maintains | Buy → Buy | — | $346.01 | $350.88 | +1.4% | +2.2% | +0.3% | +0.1% | -0.1% | +3.4% |
| Apr 22 | RBC Capital | Maintains | Outperform → Outperform | — | $346.01 | $350.88 | +1.4% | +2.2% | +0.3% | +0.1% | -0.1% | +3.4% |
| Apr 22 | Leerink Partners | Maintains | Outperform → Outperform | — | $346.01 | $350.88 | +1.4% | +2.2% | +0.3% | +0.1% | -0.1% | +3.4% |
| Apr 22 | Baird | Maintains | Underperform → Underperform | — | $346.01 | $350.88 | +1.4% | +2.2% | +0.3% | +0.1% | -0.1% | +3.4% |
| Apr 22 | Wells Fargo | Maintains | Overweight → Overweight | — | $346.01 | $350.88 | +1.4% | +2.2% | +0.3% | +0.1% | -0.1% | +3.4% |
| Apr 22 | Oppenheimer | Maintains | Outperform → Outperform | — | $346.01 | $350.88 | +1.4% | +2.2% | +0.3% | +0.1% | -0.1% | +3.4% |
| Apr 22 | Argus | Upgrade | Hold → Buy | $400 | $346.01 | $350.88 | +1.4% | +2.2% | +0.3% | +0.1% | -0.1% | +3.4% |
| Apr 22 | Morgan Stanley | Maintains | Overweight → Overweight | — | $346.01 | $350.88 | +1.4% | +2.2% | +0.3% | +0.1% | -0.1% | +3.4% |
| Apr 22 | Barclays | Maintains | Overweight → Overweight | — | $346.01 | $350.88 | +1.4% | +2.2% | +0.3% | +0.1% | -0.1% | +3.4% |
| Apr 20 | Jefferies | Maintains | Buy → Buy | — | $324.63 | $324.19 | -0.1% | -0.4% | +7.0% | +2.2% | +0.3% | +0.1% |
| Apr 7 | Bernstein | Maintains | Outperform → Outperform | — | $281.36 | $308.85 | +9.8% | +9.4% | -0.6% | +0.3% | -0.8% | +2.8% |
| Apr 1 | Raymond James | Upgrade | Market Perform → Outperform | — | $270.59 | $274.21 | +1.3% | +1.3% | +1.2% | +1.5% | +9.4% | -0.6% |
| Feb 5 | Mizuho | Maintains | Outperform → Outperform | — | $275.92 | $274.29 | -0.6% | -2.7% | +3.0% | -0.3% | -0.9% | +2.1% |
| Feb 2 | Truist | Maintains | Buy → Buy | — | $286.93 | $286.02 | -0.3% | -0.5% | -0.5% | -2.9% | -2.7% | +3.0% |
| Feb 2 | JP Morgan | Maintains | Overweight → Overweight | — | $286.93 | $286.02 | -0.3% | -0.5% | -0.5% | -2.9% | -2.7% | +3.0% |
| Jan 30 | Wells Fargo | Maintains | Overweight → Overweight | — | $292.29 | $292.10 | -0.1% | -1.8% | -0.5% | -0.5% | -2.9% | -2.7% |
| Jan 30 | Barclays | Maintains | Overweight → Overweight | — | $292.29 | $292.10 | -0.1% | -1.8% | -0.5% | -0.5% | -2.9% | -2.7% |
| Jan 28 | RBC Capital | Maintains | Outperform → Outperform | — | $282.70 | $283.72 | +0.4% | +4.0% | -0.6% | -1.8% | -0.5% | -0.5% |
| Jan 28 | UBS | Maintains | Buy → Buy | — | $282.70 | $283.72 | +0.4% | +4.0% | -0.6% | -1.8% | -0.5% | -0.5% |
| Jan 28 | Leerink Partners | Maintains | Outperform → Outperform | — | $282.70 | $283.72 | +0.4% | +4.0% | -0.6% | -1.8% | -0.5% | -0.5% |
| Jan 28 | Oppenheimer | Maintains | Outperform → Outperform | — | $282.70 | $283.72 | +0.4% | +4.0% | -0.6% | -1.8% | -0.5% | -0.5% |
| Jan 28 | Jefferies | Maintains | Buy → Buy | — | $282.70 | $283.72 | +0.4% | +4.0% | -0.6% | -1.8% | -0.5% | -0.5% |
| Jan 23 | Morgan Stanley | Maintains | Overweight → Overweight | — | $354.47 | $354.28 | -0.1% | +0.5% | -1.3% | -19.6% | +4.0% | -0.6% |
| Jan 5 | Barclays | Maintains | Overweight → Overweight | — | $336.40 | $335.45 | -0.3% | +1.7% | +2.0% | -2.1% | +1.5% | -0.8% |
| Oct 30 | Bernstein | Maintains | Outperform → Outperform | — | $355.26 | $347.52 | -2.2% | -3.0% | -0.9% | -2.3% | -0.9% | -0.9% |
| Oct 30 | TD Cowen | Maintains | Hold → Hold | — | $355.26 | $347.52 | -2.2% | -3.0% | -0.9% | -2.3% | -0.9% | -0.9% |
| Oct 29 | RBC Capital | Maintains | Outperform → Outperform | — | $367.84 | $364.28 | -1.0% | -3.4% | -3.0% | -0.9% | -2.3% | -0.9% |
| Oct 29 | Piper Sandler | Maintains | Overweight → Overweight | — | $367.84 | $364.28 | -1.0% | -3.4% | -3.0% | -0.9% | -2.3% | -0.9% |
| Oct 29 | UBS | Maintains | Buy → Buy | — | $367.84 | $364.28 | -1.0% | -3.4% | -3.0% | -0.9% | -2.3% | -0.9% |
| Oct 17 | Jefferies | Maintains | Buy → Buy | — | $356.67 | $351.00 | -1.6% | -0.0% | +2.2% | +0.2% | -1.1% | -0.3% |
| Oct 9 | Mizuho | Maintains | Outperform → Outperform | — | $369.92 | $372.52 | +0.7% | -0.6% | -3.6% | +1.2% | +0.4% | +0.3% |
| Oct 9 | Barclays | Maintains | Overweight → Overweight | — | $369.92 | $372.52 | +0.7% | -0.6% | -3.6% | +1.2% | +0.4% | +0.3% |
| Oct 9 | JP Morgan | Maintains | Overweight → Overweight | — | $369.92 | $372.52 | +0.7% | -0.6% | -3.6% | +1.2% | +0.4% | +0.3% |
| Oct 8 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $363.66 | $366.93 | +0.9% | +1.7% | -0.6% | -3.6% | +1.2% | +0.4% |
| Oct 8 | Bernstein | Maintains | Outperform → Outperform | — | $363.66 | $366.93 | +0.9% | +1.7% | -0.6% | -3.6% | +1.2% | +0.4% |
| Oct 8 | BofA Securities | Maintains | Neutral → Neutral | — | $363.66 | $366.93 | +0.9% | +1.7% | -0.6% | -3.6% | +1.2% | +0.4% |
| Oct 7 | Wells Fargo | Maintains | Overweight → Overweight | — | $358.77 | $359.41 | +0.2% | +1.4% | +1.7% | -0.6% | -3.6% | +1.2% |
| Sep 12 | Morgan Stanley | Maintains | Overweight → Overweight | — | $353.61 | $355.90 | +0.6% | -0.3% | -1.3% | -2.3% | +0.5% | -2.0% |
| Sep 9 | Truist | Maintains | Buy → Buy | — | $320.25 | $332.50 | +3.8% | +8.6% | -0.3% | +2.0% | -0.3% | -1.3% |
| Sep 5 | Bernstein | Maintains | Outperform → Outperform | — | $310.38 | $310.44 | +0.0% | +1.6% | +1.5% | +8.6% | -0.3% | +2.0% |
| Sep 4 | Barclays | Maintains | Overweight → Overweight | — | $307.88 | $306.10 | -0.6% | +0.8% | +1.6% | +1.5% | +8.6% | -0.3% |
| Aug 26 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $304.86 | $304.31 | -0.2% | -1.5% | +1.1% | -0.5% | +2.5% | -0.3% |
| Aug 20 | Morgan Stanley | Maintains | Overweight → Overweight | — | $304.24 | $306.40 | +0.7% | -1.4% | +1.2% | +1.3% | -0.8% | -1.5% |
| Aug 18 | BofA Securities | Maintains | Neutral → Neutral | — | $304.01 | $313.18 | +3.0% | +1.5% | -1.4% | -1.4% | +1.2% | +1.3% |
| Aug 7 | Mizuho | Maintains | Outperform → Outperform | — | $245.78 | $246.42 | +0.3% | -0.5% | +2.5% | +0.6% | +3.6% | +3.9% |
| Aug 6 | JP Morgan | Maintains | Overweight → Overweight | — | $251.00 | $250.64 | -0.1% | -2.1% | -0.5% | +2.5% | +0.6% | +3.6% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Apr 23, 2026 | Conway Patrick HughOff | Chief Executive Officer, Optum | Sell | 800 | $355.00 | $284K | 17,804 | +3.41% | +0.53% |
8-K · 7.01
! Medium
UnitedHealth Group Incorporated -- 8-K 7.01: Regulation FD Disclosure
May 11
8-K
UNITEDHEALTH GROUP INCORPORATED (Delaware) -- 8-K Filing
UnitedHealth Group raised its 2026 adjusted earnings guidance to above $18.25 per share, signaling confidence in its healthcare modernization strategy and operational performance.
Apr 21
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
Uncertainty around leadership transitions at UnitedHealth could create near-term stock volatility, though investors should monitor whether the successor demonstrates capability to navigate ongoing regulatory pressures in healthcare.
Mar 12
8-K · 7.01
! Medium
UNITEDHEALTH GROUP INCORPORATED (Delaware) -- 8-K 7.01: Regulation FD Disclosure
UnitedHealth Group's senior leadership will discuss strategy, market positions, and business outlook at the Barclays Healthcare Conference on March 10, 2026, with live webcast access available.
Mar 9
8-K · 5.02
!!! Very High
UNITEDHEALTH GROUP INCORPORATED (Delaware) -- 8-K 5.02: Executive Change
UnitedHealth Group appoints Dennis Stankiewicz as director effective March 2, 2026, expanding its board composition with new governance representation.
Mar 2
8-K · 5.02
!!! Very High
UNITEDHEALTH GROUP INCORPORATED (Delaware) -- 8-K 5.02: Executive Change
UnitedHealth Group amended Stephen Hemsley's stock option grant with additional share-holding restrictions, extending incentive alignment beyond the original three-year cliff vesting period.
Feb 25
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Vanguard Capital Management Llc | 58,870,777 | $15.9B | New | Mar 2026 |
| 2 | Morgan Stanley | 31,580,190 | $10.4B | Added | Dec 2025 |
| 3 | Capital World Investors | 27,783,415 | $7.5B | Added | Mar 2026 |
| 4 | Vanguard Portfolio Management Llc | 24,036,504 | $6.5B | New | Mar 2026 |
| 5 | Jpmorgan Chase & Co | 19,102,541 | $5.0B | Added | Mar 2026 |
| 6 | Capital Research Global Investors | 17,112,218 | $4.6B | Added | Mar 2026 |
| 7 | Fmr Llc | 12,019,046 | $3.3B | Reduced | Mar 2026 |
| 8 | Bank Of America Corp /de/ | 11,713,684 | $3.2B | Added | Mar 2026 |
| 9 | Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main | 5,079,476 | $3.0B | Added | Sep 2024 |
| 10 | Bank Of New York Mellon Corp | 10,088,271 | $2.7B | Added | Mar 2026 |
| 11 | Dodge & Cox | 9,466,756 | $2.6B | Added | Mar 2026 |
| 12 | Northern Trust Corp | 8,779,907 | $2.4B | Reduced | Mar 2026 |
| 13 | Amundi | 6,376,198 | $1.7B | New | Mar 2026 |
| 14 | Invesco Ltd. | 6,316,462 | $1.7B | Added | Mar 2026 |
| 15 | Sanders Capital, Llc | 5,964,685 | $1.6B | Reduced | Mar 2026 |
| 16 | Franklin Resources Inc | 5,674,123 | $1.5B | Reduced | Mar 2026 |
| 17 | Royal Bank Of Canada | 5,319,248 | $1.4B | Reduced | Mar 2026 |
| 18 | Jane Street Group, Llc | 3,468,337 | $1.1B | Added | Dec 2025 |
| 19 | Janus Henderson Group Plc | 3,691,607 | $991M | New | Mar 2026 |
| 20 | Ubs Group Ag | 3,452,797 | $934M | Added | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$364.87B
Enterprise Value
$409.07B
P/E (TTM)
30.31x
Forward P/E
21.94x
PEG Ratio
-1.62x
P/B
3.59x
P/S
0.82x
P/FCF
22.70x
EV/EBITDA
17.74x
Shares Out
910.0M
Financials (TTM)
Revenue
$447.57B
Net Income
$12.06B
EBITDA
$23.06B
Free Cash Flow
$16.07B
Op Cash Flow
$19.70B
EPS Basic
$13.23
EPS Diluted
$13.23
EPS Forward
$18.27
Gross Margin
18.5%
Op Margin
4.2%
Net Margin
2.7%
Balance Sheet
Total Assets
$309.58B
Total Liab.
$207.88B
Total Equity
$101.70B
Cash
$28.12B
LT Debt
$72.32B
Book Value/Sh
$111.76
Debt/Equity
0.83x
Current Ratio
0.79
Quick Ratio
0.79
Returns & Growth
ROE
36.5%
ROA
3.9%
ROIC
8.2%
Rev Growth YoY
+11.8%
EPS Growth YoY
-15.4%
Price Returns
2W
-4.7%
1M
+2.7%
3M
+29.7%
6M
+15.3%
12M
+26.0%
Technicals
52W High
$413.00
52W Low
$237.77
50d MA
$372.67
200d MA
$333.56
RSI (14)
65.80
ATR (14)
$8.85
Beta
0.41
Avg Volume
7.1M
Dividends
Div Rate
$8.70
Div Yield
2.4%
Frequency
4
Ex-Div Date
Mar 9, 2026
Analyst Price Targets
Consensus
$381.62
High
$444.00
Low
$327.00
Median
$375.00
Data updated apr 27, 2026 6:50am
· Source: financialmodelingprep.com